ne pas avoir t fabriqus ou entreposs de faon scuritaire
BPC-157 has demonstrated protective effects against NSAID-induced gastric damage in research, but whether this translates to clinical interaction effects remains unclear
Peptides have exploded over the last few years
Subjective feelings alone are insufficientuse quantifiable metrics to guide protocol adjustments
Years of experience helping thousands of clients with hangovers has allowed us to dial in the formula for this special drip
| | Intensive Performance Protocol | 10mg subcutaneous, 5x/week (weekdays) | 150mg oral, daily | Both compounds AM, pre-training | 6 weeks on, 4 weeks off | Athletic performance research, substrate utilization studies, endurance capacity trials | Higher dosing frequency and dose intensity produce more pronounced short-term shifts in RER and VO2 max, but require stricter adherence and increase washout sensitivity